Continuous positive airway pressure (CPAP) machines and other sleep apnea devices are designed to maintain open airways during sleep by providing a steady flow of air, preventing the breathing interruptions characteristic of sleep disorders such as obstructive sleep apnea syndrome (OSAS).
These devices are also beneficial for individuals suffering from other respiratory conditions, including Chronic Obstructive Pulmonary Disease (COPD).
For many people, CPAP devices and other products used to alleviate obstructive sleep apnoea greatly improve their quality of life.
In June 2021, Philips Respironics announced a recall of over 15 million CPAP machines, BiPAP machines, and Ventilators due to risk of serious injury and health problems.
The recall was initiated due to the discovery that the polyester-based polyurethane (PE-PUR) sound abatement foam used in these devices could degrade into particles, potentially being inhaled or ingested by users.
The degradation of PE-PUR foam in Philips breathing machines could pose an increased risk of cancer and other associated injury.
Lawsuits are now being filed against Philips for cancer, respiratory problems, and other health problems associated with CPAP machines produced by the company.
If you or a loved one used a defective Philips CPAP machine and received a cancer diagnosis or have experienced other related health issues, you may be eligible to file a lawsuit.
Contact TorHoerman Law today for a free consultation with our Philips CPAP Lawyers.
You can also use the chatbot on this page to find out if you qualify to join others filing Philips CPAP Lawsuits today.
List of Recalled Philips CPAP Machines, BiPAP Machines, and Ventilator Devices
In June 2021, Philips Respironics initiated a recall for millions of its CPAP, BiPAP, and ventilator devices due to potential health risks posed by the degradation of polyester-based polyurethane (PE-PUR) sound abatement foam.
This recall covered products manufactured between 2009 and April 26, 2021, and was classified as a Class 1 recall by the U.S. FDA, indicating that use of these devices could cause serious injuries or death.
The recall aimed to address the risk of users inhaling or ingesting toxic particles or being exposed to harmful chemicals released by the degrading foam.
Recalled Philips CPAP Machines, BiPAP Machines, and Ventilator Devices include:
- A-Series BiPAP A30
- A-Series BiPAP A40 (ventilator)
- A-Series BiPAP Hybrid A30
- A-Series BiPAP V30 Auto (ventilator)
- C-Series ASV (ventilator)
- C-Series S/T and AVAPS
- DreamStation
- DreamStation ASV
- DreamStation Go
- DreamStation ST, AVAPS
- Dorma 400
- Dorma 500
- E30
- Garbin Plus
- Aeris
- LifeVent (ventilator)
- OmniLab Advanced+
- REMstar SE Auto
- SystemOne ASV4
- SystemOne (Q-Series)
- Trilogy 100 (ventilator)
- Trilogy 200 (ventilator)
Additionally, certain Trilogy Evo ventilators distributed from April 15, 2021, to May 24, 2021, with specific serial numbers, were also included in the recall.
